NEWS
New Feature!!!! University Subject Rankings in 12 branches
FOR SCIENTIST REGISTRATION FOR INSTITUTIONAL BULK REGISTRATION
FOR EDIT YOUR UNIVERSITY / INSTITUTION PAGE
Some differences of the AD Scientific Index
New Feature!!!! University Subject Rankings in 12 branches
List without CERN, Statistical Data etc. Only in AD Scientific Index
New Feature!!!! University Subject Rankings in 12 branches
AD
Scientific Index 2024
About Us
Methodology
Compare & Choose
Contact - FAQ
login
Login
person_add
Register
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
school
University Rankings
subject
University Subject Rankings
insights
Subject Rankings
place
Country Rankings
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
local_fire_department
Country Top Lists
Matthew W Hagen
Oregon Health & Science University - Portland / United States
Medical and Health Sciences / Health Sciences
AD Scientific Index ID: 885971
Edit Form
Registration, Add Profile,
Premium Membership
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Congresses (0)
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Matthew W Hagen's MOST POPULAR ARTICLES
1-)
Prenatal cerebral ischemia disrupts MRI-defined cortical microstructure through disturbances in neuronal arborizationJM Dean, E McClendon, K Hansen, A Azimi-Zonooz, K Chen, A Riddle, ...Science translational medicine 5 (168), 168ra7-168ra7, 20131632013
2-)
Prenatal cerebral ischemia triggers dysmaturation of caudate projection neuronsE McClendon, K Chen, X Gong, E Sharifnia, M Hagen, V Cai, DC Shaver, ...Annals of neurology 75 (4), 508-524, 2014752014
3-)
Contact activation inhibitor and factor XI antibody, AB023, produces safe, dose-dependent anticoagulation in a phase 1 first-in-human trialCU Lorentz, NG Verbout, M Wallisch, MW Hagen, JJ Shatzel, SR Olson, ...Arteriosclerosis, thrombosis, and vascular biology 39 (4), 799-809, 2019812019
4-)
Thrombogenicity of flow diverters in an ex vivo shunt model: effect of phosphorylcholine surface modificationMW Hagen, G Girdhar, J Wainwright, MT HindsJournal of neurointerventional surgery 9 (10), 1006-1011, 2017812017
5-)
A TLR/AKT/FoxO3 immune tolerance–like pathway disrupts the repair capacity of oligodendrocyte progenitorsT Srivastava, P Diba, JM Dean, F Banine, D Shaver, M Hagen, X Gong, ...The Journal of Clinical Investigation 128 (5), 2025-2041, 2018512018
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept